Cargando…

Comparison of Outcomes of Active Surveillance in Intermediate-Risk Versus Low-Risk Localised Prostate Cancer Patients: A Systematic Review and Meta-Analysis

Currently, there is no clear consensus regarding the role of active surveillance (AS) in the management of intermediate-risk prostate cancer (IRPC) patients. We aim to analyse data from the available literature on the outcomes of AS in the management of IRPC patients and compare them with low-risk p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mukherjee, Subhabrata, Papadopoulos, Dimitrios, Norris, Joseph M., Wani, Mudassir, Madaan, Sanjeev
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094761/ https://www.ncbi.nlm.nih.gov/pubmed/37048815 http://dx.doi.org/10.3390/jcm12072732

Ejemplares similares

Active Surveillance—Is It Feasible for Intermediate-risk Localised Prostate Cancer?
por: Mukherjee, Subhabrata, et al.
Publicado: (2021)

Venous Thromboembolism (VTE) in Post-Prostatectomy Patients: Systematic Review and Meta-Analysis
por: Wani, Mudassir, et al.
Publicado: (2023)

What Is New in the Management of High-Risk Localized Prostate Cancer?
por: Wani, Mudassir, et al.
Publicado: (2023)

Is there a role for stem cell therapy in erectile dysfunction secondary to cavernous nerve injury? Network meta-analysis from animal studies and human trials
por: Wani, Mudassir M., et al.
Publicado: (2022)

Effects of Delayed Radical Prostatectomy and Active Surveillance on Localised Prostate Cancer—A Systematic Review and Meta-Analysis
por: Chan, Vinson Wai-Shun, et al.
Publicado: (2021)

Active Surveillance for Intermediate Risk Prostate Cancer
por: Dall'Era, Marc A., et al.
Publicado: (2016)

Active surveillance in intermediate risk prostate cancer: is it safe?
por: Henk, G. van der Poel, et al.
Publicado: (2016)

Active surveillance in intermediate risk prostate cancer: is it safe?
por: Krishnananthan, Nishanth, et al.
Publicado: (2016)

Urological Implications Associated with the Use of Recreational Drugs: A Narrative Review
por: Wani, Mudassir, et al.
Publicado: (2022)

Communicating risk in active surveillance of localised prostate cancer: a protocol for a qualitative study
por: Rapport, Frances, et al.
Publicado: (2017)

Transperineal laser ablation as a new minimally invasive surgical therapy for benign prostatic hyperplasia: a systematic review of existing literature
por: Tzelves, Lazaros, et al.
Publicado: (2023)

Active surveillance and focal therapy for low-intermediate risk prostate cancer
por: Klotz, Laurence
Publicado: (2015)

Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current Data
por: Blas, Leandro, et al.
Publicado: (2022)

The cost-effectiveness of active surveillance compared to watchful waiting and radical prostatectomy for low risk localised prostate cancer
por: Lao, Chunhuan, et al.
Publicado: (2017)

No significant difference in intermediate key outcomes in men with low- and intermediate-risk prostate cancer managed by active surveillance
por: Cyll, Karolina, et al.
Publicado: (2022)

Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer
por: Beckmann, Kerri, et al.
Publicado: (2021)

Comparison of Multiparametric Magnetic Resonance Imaging with Prostate-Specific Membrane Antigen Positron-Emission Tomography Imaging in Primary Prostate Cancer Diagnosis: A Systematic Review and Meta-Analysis
por: Zhao, Yi, et al.
Publicado: (2022)

Biomarker in Active Surveillance for Prostate Cancer: A Systematic Review
por: Manceau, Cécile, et al.
Publicado: (2021)

High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trial
por: Nair-Shalliker, Visalini, et al.
Publicado: (2021)

Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial
por: Shore, Neal D., et al.
Publicado: (2022)

The Evolving Role of Radiofrequency Guided Localisation in Breast Surgery: A Systematic Review
por: Tayeh, Salim, et al.
Publicado: (2021)

The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer
por: Koerber, Florian, et al.
Publicado: (2014)

Influence of Active Surveillance on Gleason Score Upgrade and Prognosis in Low- and Favorable Intermediate-Risk Prostate Cancer
por: Hu, Xuanhan, et al.
Publicado: (2022)

Benefit and harm of lymphadenectomy in intermediate risk prostate cancer: comparison of five nomograms
por: Lodeta, Branimir, et al.
Publicado: (2023)

Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
por: Wilkins, Anna, et al.
Publicado: (2015)

Advancing Risk Assessment of Intermediate Risk Prostate Cancer Patients
por: Drachenberg, Darrel, et al.
Publicado: (2019)

Cloud Platforms for Context-Adaptive Positioning and Localisation in GNSS-Denied Scenarios—A Systematic Review
por: Quezada-Gaibor, Darwin, et al.
Publicado: (2021)

Diet quality and Gleason grade progression among localised prostate cancer patients on active surveillance
por: Gregg, Justin R., et al.
Publicado: (2019)

Cause-specific mortality of low and selective intermediate-risk prostate cancer patients with active surveillance or watchful waiting
por: Wu, Xiangkun, et al.
Publicado: (2021)

Active surveillance in males with low- to intermediate-risk localized prostate cancer: A modern prospective cohort study
por: Rakauskas, Arnas, et al.
Publicado: (2021)

Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018
por: Parikh, Ravi B., et al.
Publicado: (2020)

Stereotactic Body Radiotherapy for High-Risk Prostate Cancer: A Systematic Review
por: Foerster, Robert, et al.
Publicado: (2021)

High- or Intermediate-Risk Histologic Features in Patients with Clinical Early-Stage Cervical Cancer Planned for Fertility-Sparing Surgery: A Systematic Review
por: Wolswinkel, Janneke T., et al.
Publicado: (2023)

Comparison between upfront surgery and neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A systematic review
por: Fiflis, Stylianos, et al.
Publicado: (2023)

MRI for managing intermediate & low risk prostate cancer
por: Padhani, Anwar R
Publicado: (2014)

Long-term and pathological outcomes of low- and intermediate-risk prostate cancer after radical prostatectomy: implications for active surveillance
por: Meissner, Valentin H., et al.
Publicado: (2021)

Determinants for choosing and adhering to active surveillance for localised prostate cancer: a nationwide population-based study
por: Bergengren, Oskar, et al.
Publicado: (2019)

Comparison of EBRT and I-125 seed brachytherapy concerning outcome in intermediate-risk prostate cancer
por: Moll, Matthias, et al.
Publicado: (2021)

The direct prognosis comparison of (125)I low-dose-rate brachytherapy versus laparoscopic radical prostatectomy for patients with intermediate-risk prostate cancer
por: Liang, Zhen, et al.
Publicado: (2023)

Systematic Review with Meta-Analysis: Comparison of the Risk of Hepatocellular Carcinoma in Antiviral-Naive Chronic Hepatitis B Patients Treated with Entecavir versus Tenofovir: The Devil in the Detail
por: Oh, Hyunwoo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_11rf54qoo7b6gv71r1ha8k3gg8